#USA #San Francisco #Hypnosis #Reveri #Dr. David Spiegel

Study Unveils the Widespread Hypnotizability of the Population

A recent analysis led by Reveri, a pioneering self-hypnosis application co-founded by Dr. David Spiegel—an Associate Chair of Psychiatry at Stanford University—has revealed a fascinating new insight into the human mind. The study, which analyzed over 100,000 users, found that approximately 60.3% of individuals possess the ability to be hypnotized, with 35% categorized as 'highly hypnotizable.' This significant finding sheds light on the potential for utilizing self-hypnosis as a tool for personal development and healing.

The Science Behind Hypnotizability

The research led by Dr. Spiegel didn't stop at merely identifying the proportions of hypnotizable individuals. It ventured into the genetics behind this phenomenon. Recent studies from his lab indicate that certain genetic variants, notably in the catechol-O-methyltransferase (COMT) gene, play a crucial role in determining how susceptible a person is to hypnosis. This connection between genetics and hypnotizability explains why some people respond more readily to self-hypnosis techniques than others.

Self-Hypnosis as an Effective Tool

Dr. Spiegel's self-hypnosis methods have been developed over 45 years and are supported by over 400 peer-reviewed studies. They have shown efficacy in offering quick, drug-free relief from various issues such as pain, insomnia, and stress, as well as in helping individuals break detrimental habits like smoking or vaping. The core of this approach involves an interactive hypnotizability test—accessible within the Reveri app. This 10-minute session guides users through questions and moments of reflection, ultimately helping them gauge their level of hypnotizability.

The Importance of These Findings

• - Broad Applicability: The high percentage of users found to be hypnotizable underscores that a substantial portion of the population can experience benefits through self-hypnosis. This factor makes it a viable alternative for those seeking non-pharmacological methods for managing stress or health issues.
• - Genetic Influence: By linking hypnotizability to geneticmarkers, the research opens up new pathways for understanding individual differences in psychological responses and could lead to personalized approaches in therapeutic settings.
• - Drug-Free Relief: The findings advocate for self-hypnosis as an effective way to address mental and physical health challenges without the side effects associated with many medications.
• - Quick Results: Many users have reported seeing results just after a few sessions, a testament to the effectiveness and speed of this technique. Individuals may find relief or improvement in a short time, making it appealing for those in need of immediate support.
• - Accessibility of Tools: The Reveri app provides an easy entry point for individuals to explore self-hypnosis. With a free trial and an interactive hypnotherapy session, users can conveniently access the tools they need to enhance their mental well-being.

About Reveri

Reveri, founded by Dr. David Spiegel, combines clinical rigor with technological convenience, providing a platform where users can leverage their innate potential to tackle issues such as anxiety, stress, and sleep disturbances. The results users are achieving in mere minutes highlight the profound impact of this scientifically-supported method.

Learn More

For those interested in exploring the benefits of self-hypnosis or to learn more about Dr. Spiegel's groundbreaking work in this field, further information can be found at Reveri's official website.

Dr. David Spiegel continues to contribute significantly to the understanding of how hypnosis can alter brain function and improve quality of life, supported by years of academic inquiry and practical application.